Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Pinals

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Psychiatric Annals|June 6, 2003
Sanctity, secrecy, and silence: dilemmas in clinical confidentialityD A Pinals, T G Gutheil
The Israel Journal of Psychiatry and Related Sciences|September 20, 2000
The history and current status of competence and informed consent in psychiatric researchD A Pinals, P S Appelbaum
The Journal of the American Academy of Psychiatry and the Law|April 22, 1999
Novel antipsychotic agents and their implications for forensic psychiatryD A Pinals, P F Buckley
Wisconsin Law Review|November 12, 2005
Old law meets new medicine: revisiting involuntary psychotropic medication of the criminal defendantD M Siegel, A J Grudzinskas, D A Pinals
Psychiatric Services (Washington, D.C.)|May 9, 1998
Informed consent in schizophrenia researchD A Pinals, A K Malhotra, A Breier, et al.
Schizophrenia Research|December 15, 1996
Lack of gender differences in neuroleptic response in patients with schizophreniaD A Pinals, A K Malhotra, C D Missar, et al.
The American Journal of Psychiatry|June 1, 1997
Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteersA Breier, A K Malhotra, D A Pinals, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 1, 1997
Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenicsA K Malhotra, D A Pinals, C M Adler, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 1996
NMDA receptor function and human cognition: the effects of ketamine in healthy volunteersA K Malhotra, D A Pinals, H Weingartner, et al.
The American Journal of Psychiatry|February 16, 1999
Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine responseA F Breier, A K Malhotra, T P Su, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Psychiatric Annals|June 6, 2003
Sanctity, secrecy, and silence: dilemmas in clinical confidentialityD A Pinals, T G Gutheil
The Israel Journal of Psychiatry and Related Sciences|September 20, 2000
The history and current status of competence and informed consent in psychiatric researchD A Pinals, P S Appelbaum
The Journal of the American Academy of Psychiatry and the Law|April 22, 1999
Novel antipsychotic agents and their implications for forensic psychiatryD A Pinals, P F Buckley
Wisconsin Law Review|November 12, 2005
Old law meets new medicine: revisiting involuntary psychotropic medication of the criminal defendantD M Siegel, A J Grudzinskas, D A Pinals
Psychiatric Services (Washington, D.C.)|May 9, 1998
Informed consent in schizophrenia researchD A Pinals, A K Malhotra, A Breier, et al.
Schizophrenia Research|December 15, 1996
Lack of gender differences in neuroleptic response in patients with schizophreniaD A Pinals, A K Malhotra, C D Missar, et al.
The American Journal of Psychiatry|June 1, 1997
Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteersA Breier, A K Malhotra, D A Pinals, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 1, 1997
Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenicsA K Malhotra, D A Pinals, C M Adler, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 1996
NMDA receptor function and human cognition: the effects of ketamine in healthy volunteersA K Malhotra, D A Pinals, H Weingartner, et al.
The American Journal of Psychiatry|February 16, 1999
Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine responseA F Breier, A K Malhotra, T P Su, et al.
Pageof 1